1/146
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
(1) MHC class I
(1) type of MHC; VIRALLY infected cell is recognized by T cytotoxic cell (CD 8)
T cytotoxic cell activated by IL 2 produced by T helper cell; activated Tc kill virally infected cell by PERFORINS and GRANZYMES
(2) MHC class I
(2) type of MHC; located on ALL nucleated cells; presents antigen to CD8 cells (T cells) destruction of cirally infected cells, tumor cells, graft rejection
(1) MHC class II
(1) type of MHC; antigen presenting cells present antigenic fragements through this MHC and is recognized by T helper cell
T helper cell produces IL 2 and becomes activated; IL 12 stimulates activated Th cells to become Th 1; IL 4 stimulates activated Th cell to Th2
(2) MHC class II
(2) type of MHC; located on antigen-presenting cells (MAC, monocyte, B cells, dendritic cells); presentation of antigen to CD4 cells (T helper cells)
T helper 1 cells
type of Th cells; produce IFN-y which activates phagocytes to kill ingested microbes; mediate TYPE IV hypersensitivity reaction and CELLULAR immunity
IFN-y
produced by Th1 cells; stimulates production of antibodies that promote ingestion of microbes by phagocytes which increases opsonization and phagocytosis
T helper 2 cells
type of Th cells; produce IL 4 which stimulates production of IgE and Il 5; mediates TYPE I hypersensitivity and HUMORAL immunity
IL 4
produced by Th2 cells; stimulates production of IgG4
IL 5
stimulates production by IL 4; activates eosinophils
IgE
stimulates production by IL 4; activates mast cells by and coats helminths for destruction by eosinophils
HLA-B27
this type of major histocompatibility complex are associated with ANKYLOSING SPONDYLITIS (has STRONGEST correlation) or BAMBOO SPINE DISEASE
HLA-DR3
this type of major histocompatibility complex are associated with SYSTEMIC LUPUS ERYTHEMATOSUS, DIABETES MELLITUS, GRAVE'S DISEASE, ADDISON'S DISEASE, MYASTHENIA GRAVIS
HLA-DR4
this type of major histocompatibility complex are associated with RHEUMATOID ARTHRITIS and DIABETES MELLITUS
HLA-B8
this type of major histocompatibility complex are associated MYASTHENIA GRAVIS, ADDISON'S DISEASE, CELIAC DISEASE, INCREASED RESISTANCE to HIV
major histocompatibility complex
HIGHLY polymorphic; HLA gene has many forms in population and makes compatibility difficult
chromosome 6
which chromosome is associated with MHC genes?
class I genes
HLA-A, HLA-B (B27 & B8), HLA-C
class II genes
HLA-D, HLA-DP, HLA-DQ, HLA-DR (DR3, DR4)
class III genes
C2, C4, factor B, TNF
serologic tissue matching
tests for MHC; donor and recipient cells are reacted with HLA antibodies; SIMPLE nad FAST
cellular tissue matching (mixed lymphocyte reaction)
tests for MHC; recipient lymphocyte proliferates; best for BONE MARROW GRAFTS and LIVING RELATED DONORS; tests for HLA-D (CLASS II)
mitomycin C or irradiation
in mixed lymphocyte reaction; used to INACTIVATE donor lymphocyte
thymidine
in mixed lymphocyte reaction, used to measure amount of proliferation
molecular tissue matching (restriction fragment length polymorphism)
tests for MHC; enzymes that cleave DNA are used to obtain patterns; DNA sequences are amplified by PCR; genetic disparity is assessed; FASTEST and SUPERIOR
HLA class I typing
tissue typing
a. requires only 1-2 mL of serum
b. lymphocytes are incubated with panel of HLA-antibodies and complement is added
c. if HLA antigen specific to HLA antibody is present, complement is activated and kills cells
ACD or heparinized blood
type of sample used in HLA class I typing
ficoll-hypaque centrifugation
obtains purified lymphocyte suspension in HLA class I typing
eosin Y or trypan blue
dye used to visualize in HLA class I typing
uninjured cells
in HLA class I typing; small, bright, refractile; NEGATIVE reaction -> NOT lysed
injured cells
in HLA class I typing; flattened, large, dark, nonrefractile; POSITIVE reaction -> LYSED meaning antigen present
HLA class II typing
tissue typing; HLA-DR typing requires identification of B lymphocytes; B cells adhere to NYLON WOOL and can be eluted
nylon wool separation (elution)
in HLA class II typing, prepares B lymphocyte suspension
antigen
substance that triggers an immune response and reacts with antibody
hapten
part of antigen; non immunogenic materials (when combined with carrier will create new antigenic determinants); INcomplete antigen
schlepper molecule (carrier molecule)
part of antigen; IMMUNOGENIC; coupled with haptenic groups which will confer new antigenic specificities
immunogen
substance that can induce immune response
foreignness
factors influencing immunogenicity; greater the difference between substance and host, MORE potent is its antigenic qualities
<1 kilodalton
size of NON immunogenic molecule
6 kD or more
size of STRONG immunogen molecules
at least 1 kD or 10,000 Daltons
size of molecule to be immunogenic
chemical composition
factors influencing immunogenicity; MORE COMPLEX the substance, MORE IMMUNOGENIC; protein have HIGH molecular weight therefore they are GOOD immunogens
dose
factors influencing immunogenicity; method of administration wherein there is a dose of antigen above or below which immune response will NOT be optimal
route
factors influencing immunogenicity; method of administration wherein subcutaneous or intramuscular route is BETTER than intravenous or intragastric routes
adjuvants
factors influencing immunogenicity; substances that can ENHANCE immune responses
alum precipitate
used in human vaccines; used to complex with immunogen to increase its size and prevent rapid escape from tissues
squaline or Mf59
type of adjuvant; obtained from shark's oil (HIV vaccine development)
freund's complete adjucant
type of adjucant; water in oil emulsion of killed MTB or B. pertussis, enhances cell mediated immunity; NOT used for human vaccines because it produces large granuloma
autoantigen
antigen from SAME individual
alloantigen
antigen from DIFFERENT individual but SAME species
heteroantigen
antigen from DIFFERENT species
heterophile antigens
heteroantigens that exist in unrelated plants or animals but are either identical or closely related in structure so that antibody to one will cross-react with antigen of the other
autograft
graft of tissue from one's own body
isograft (syngraft)
graft from DIFFERENT but identical individual
allograft
graft from DIFFERENT individuals but SAME species (fetus on mother's womb)
heterograft (xenograft)
graft from DIFFERENT species (pig's heart valves)
bone marrow
MOST IMMUNOGENIC organ that can be transplanted
cornea
LEAST IMMUNOGENIC organ that can be transplanted
hyperacute graft rejection
-type of graft rejection occurring WITHIN MINUTES
-mechanism is HUMORAL; caused by preformed cytotoxic antibodies to donor antigens
accelerated graft rejection
-type of graft rejection occurring 2-5 DAYS
-CELL-MEDIATED; caused by previous sensitization to donor antigens
acute graft rejection
-type of graft rejection occurring 7-21 DAYS
-CELL-MEDIATED; caused by allogeneic reaction to donor antigens
chronic graft rejection
-type of graft rejection occurring more than 3 MONTHS
-CELL-MEDIATED; caused by disturbance of host vs. graft tolerance
antibodies
specialized proteins that aid in destroying infectious agents; SPECIFIC glycoproteins referred to as IMMUNOGLOBULINS; produced in response to antigenic stimulation
immunoglobulins
antibodies that neutralize toxic substance, facilitate phagocytosis (opsonization), kill microbes, combine with antigen on cell surfaces and cause destruction of cells
heavy chain
gamma, alpha, mu, epsilon, and delta; each chain combines equally well with any light chain
light chain
lambda and kappa; antibodies will always have two identical type of this chains
kappa
type of light chain found in chromosome 2
lambda
type of light chain found in chromosome 22
disulfide bonds
type of bonds that connects heavy chain to heavy chain and heavy chain to light chain
bence jone proteins
proteins with light chain to light chain connection
hinge region
located between constant heavy 1 and constant heavy 2; allows immunoglobulin to take on different shapes
proline
high content of this substance in hinge region gives immunoglobulin flexibility
variable domain
part of region; responsible for binding antigen; varies to allow B cells to produce antibodies to many different antigens; UPPER portion of Fab which binds to SPECIFIC antigen
constant domain
part of region; LOWER portion of FAB and activates compliment cascade
isotype
-type of antibodies found in all different individuals in related species
-HEAVY chain of each immunoglobulin class
allotype
-type of antibodies found within one species
-VARIATION in CONSTANT region
idiotype
-type of antibodies found within one individual
-variations in VARIABLE region
valence
number of binding sites
papain
cleaves immunoglobulin into 3 fragments; cleaves ABOVE hinge region; has 2 Fab and 1 Fc
pepsin
cleaves immunoglobulin into 2 fragments; cleaves BELOW hinge region; has F(ab)2 and Fc'
F(ab)2
fragment of immunoglobulin molecule obtained by pepsin cleavage that consists of two light chains and two heavy-chain halves held together by disulfide bonding; MAJOR fragmentation product of pepsin
(1) IgM
(1) immunoglobulin; PRIMARY response to antibody; FIRST to appear after antigenic stimulation and maturing infant; synthesized only as long as antigen remains present (has NO memory cells
(2) IgM
(2) immunoglobulin; function as complement fixation, agglutination, opsonization, toxin neutralization; MOST efficient at triggering classical complemnt activity; potent AGAINST gram (-) bacteria
(3) IgM
(3) immunoglobulin; efficient at AGGLUTINATION which causes CLUMPING together of LARGER particles (RBCs) and cytolytic response; MOST PRIMITIVE; responds to CARBOHYDRATE antigens
(1) IgG
(1) immunoglobulin; functions by providing immunity for newborn (can cross placenta), fix complement, coat antigen for enhanced phagocytosis (opsonization), neutralize toxin and viruses, participate in agglutination and precipitation reactions
(2) IgG
(2) immunoglobulin; macrophage, monocytes, neutrophil have receptors for this Ig; ENHANCE contact between antigen and phagocytic cells and INCREASE efficiency of phagocytosis
(3) IgG
(3) immunoglobulin; better at PRECIPITATION reactions because precipitation involves small soluble particles which are more EASILY brought together by relatively small IgG
(4) IgG
(4) immunoglobulin; MAJOR immunoglobulin in NORMAL serum and in ANAMNESTIC RESPONSE; LONGEST half-life of any immunoglobulin class; targeting VIRALLY infected cell for destruction by ADCC; responds best to PROTEIN antigens
IgG3
type of IgG; LARGEST hinge region and LARGEST number of interchain disulfide bonds and MOST EFFICIENT at binding complement
IG2 and IgG4
type of IgG; SHORTER hinge region which are POOR mediators of complement activation
IgG1 and IgG3
type of IgG; GOOD at initiating phagocytosis (bind most STRONGLY to Fc receptors)
(1) IgA
(1) immunoglobulin; functions to patrol mucosal surfaces and acts as first line of defense leading to neutralizing toxins produced by microorganisms and helps to prevent bacterial adherence to mucosal surface
(2) IgA
(2) immunoglobulin; found in BREAST MILK for breastfeeding helps maintain health of newborns; complexes of IgA and antigen are easily trapped in mucus and eliminated by ciliated ECs which prevents pathogens from colonizing mucosal epithelium
(3) IgA
(3) immunoglobulin; PREDOMINANT immunoglobulin in SECRETIONS; present as DIMER in secretions; binds to SECRETORY COMPONENT produced by epithelial cells which prevents enzymatic degradation forming SECRETORY IgA
(1) IgD
(1) immunoglobulin; present on surface of B cells (plats a role on B cell activation) and plays a role in regulating B cell maturation and differentiation; SUSCEPTIBLE to proteolysis -> SHORT life (1-3 days)
(2) IgD
(2) immunoglobulin; cell membrane found on surface of B cells in association with IgM; serves function in immunoregulation; helps in differentiation and maturation of B cell to plasma cell
(1) IgE
(1) immunoglobulin; mediates some type of hypersensitivity (allergic) reactions, allergies, anaphylaxis; responsible for immunity and invading PARASITES
(2) IgE
(2) immunoglobulin; originally called REAGIN; binds strongly to receptor on MAST CELLS and BASOPHILS and together with antigen, mediates release of HISTAMINE and HEPARIN from these cells
monoclonal antibodies
antibodies fused activated B cells with MYELOMA CELL (cancerous plasma cell) that can be grown indefinitely in laboratory
george kohler and cesar milstein
discover monoclonal antibodies in 1975 and was awarded the nobel prize in 1984
myeloma cell line
in monoclonal antibody, incapable of producing antibody and also deficient of HGPRT and thymidine kinase which are needed for DNA synthesis